EX-32.1 4 jagx-20230930xex32d1.htm EX-32.1

Exhibit 32.1

​

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

​

In connection with the Quarterly Report of Jaguar Health, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to such officer’s knowledge:

​

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

​

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

​

​ | ​
Date: November 14, 2023 | ​
​ | ​
​ | /s/ Lisa A. Conte
​ | Lisa A. Conte
​ | President and Chief Executive Officer
​ | (Principal Executive Officer)

​